Evaxion A/S Research and Development Expense
Evaxion A/S (EVAX) reported Research and Development Expense of $9.97 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-05
- Evaxion A/S research and development expense for the quarter ending 2025-06-30 was $2.17M, a 21.33% decline year-over-year.
- Evaxion A/S research and development expense for the quarter ending 2024-06-30 was $2.75M, a 6.27% decline year-over-year.
- Evaxion A/S research and development expense for the quarter ending 2023-06-30 was $2.94M, a 28.60% decline year-over-year.
- Evaxion A/S research and development expense for the quarter ending 2022-06-30 was $4.11M, a 19.55% decline year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 9 month | Research And Development Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $9.97M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $2.17M 6-K · filed 2025-08-14 | $4.32M 6-K · filed 2025-08-14 | ||
| 2024-12-31 | $10.46M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $2.75M 6-K · filed 2025-08-14 | $5.59M 6-K · filed 2025-08-14 | ||
| 2023-12-31 | $11.92M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $2.94M 6-K · filed 2024-08-14 | $6.79M 6-K · filed 2024-08-14 | ||
| 2022-12-31 | $17.06M 20-F · filed 2025-04-01 | |||
| 2022-06-30 | $4.11M 6-K · filed 2023-08-17 | $8.92M 6-K · filed 2023-08-17 | $15.07M derived: sum of 3 quarters · filed 2024-03-26 | $19.49M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | $4.80M 6-K · filed 2022-05-12 | $10.96M derived: sum of 2 quarters · filed 2024-03-26 | $15.38M derived: sum of 3 quarters · filed 2024-03-26 | $20.49M derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | $6.15M derived: 20-F 12 month − 6-K 9 month · filed 2024-03-26 | $10.57M derived: sum of 2 quarters · filed 2024-03-26 | $15.68M derived: sum of 3 quarters · filed 2024-03-26 | $19.58M 20-F · filed 2024-03-26 |
| 2021-09-30 | $4.42M 6-K · filed 2021-11-10 | $9.53M derived: sum of 2 quarters · filed 2022-08-11 | $13.43M 6-K · filed 2021-11-10 | $16.28M derived: sum of 4 quarters · filed 2023-04-28 |
| 2021-06-30 | $5.11M 6-K · filed 2022-08-11 | $9.00M 6-K · filed 2022-08-11 | $11.86M derived: sum of 3 quarters · filed 2023-04-28 | $14.83M derived: sum of 4 quarters · filed 2023-04-28 |
| 2021-03-31 | $3.89M 6-K · filed 2022-05-12 | $6.75M derived: sum of 2 quarters · filed 2023-04-28 | $9.71M derived: sum of 3 quarters · filed 2023-04-28 | $12.29M derived: sum of 4 quarters · filed 2023-04-28 |
| 2020-12-31 | $2.86M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-28 | $5.82M derived: sum of 2 quarters · filed 2023-04-28 | $8.39M derived: sum of 3 quarters · filed 2023-04-28 | $10.90M 20-F · filed 2023-04-28 |
| 2020-09-30 | $2.97M 6-K · filed 2021-11-10 | $5.54M derived: sum of 2 quarters · filed 2021-11-10 | $8.05M 6-K · filed 2021-11-10 | |
| 2020-06-30 | $2.57M 6-K · filed 2021-08-13 | $5.08M 6-K · filed 2021-08-13 | ||
| 2020-03-31 | $2.51M 6-K · filed 2021-05-14 | |||
| 2019-12-31 | $8.22M 20-F · filed 2022-03-31 | |||
| 2018-12-31 | $3.73M 20-F · filed 2021-04-07 |